Samrat Pharmachem reports standalone net profit of Rs 1.50 crore in the September 2019 quarter
Sales rise 61.47% to Rs 36.54 crore
Net profit of Samrat Pharmachem reported to Rs 1.50 crore in the quarter ended September 2019 as against net loss of Rs 0.09 crore during the previous quarter ended September 2018. Sales rose 61.47% to Rs 36.54 crore in the quarter ended September 2019 as against Rs 22.63 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales36.5422.63 61 OPM %5.671.02 -PBDT2.260.05 4420 PBT2.15-0.05 LP NP1.50-0.09 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content